GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grape King Bio Ltd (TPE:1707) » Definitions » Total Assets

Grape King Bio (TPE:1707) Total Assets : NT$14,940 Mil (As of Mar. 2025)


View and export this data going back to 1982. Start your Free Trial

What is Grape King Bio Total Assets?

Grape King Bio's Total Assets for the quarter that ended in Mar. 2025 was NT$14,940 Mil.

During the past 12 months, Grape King Bio's average Total Assets Growth Rate was 3.10% per year. During the past 3 years, the average Total Assets Growth Rate was 2.30% per year. During the past 5 years, the average Total Assets Growth Rate was 3.00% per year. During the past 10 years, the average Total Assets Growth Rate was 8.50% per year.

During the past 13 years, Grape King Bio's highest 3-Year average Total Assets Growth Rate was 39.50%. The lowest was 1.40%. And the median was 9.65%.

Total Assets is connected with ROA %. Grape King Bio's annualized ROA % for the quarter that ended in Mar. 2025 was 5.49%. Total Assets is also linked to Revenue through Asset Turnover. Grape King Bio's Asset Turnover for the quarter that ended in Mar. 2025 was 0.15.


Grape King Bio Total Assets Historical Data

The historical data trend for Grape King Bio's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grape King Bio Total Assets Chart

Grape King Bio Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13,104.12 14,060.88 15,053.04 15,511.84 15,323.64

Grape King Bio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15,596.96 15,048.80 14,405.90 15,323.64 14,939.80

Grape King Bio Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Grape King Bio's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=11790.695+3532.943
=15,324

Grape King Bio's Total Assets for the quarter that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (Q: Mar. 2025 )+Total Liabilities (Q: Mar. 2025 )
=11527.62+3412.183
=14,940

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grape King Bio  (TPE:1707) Total Assets Explanation

Total Assets is connected with ROA %.

Grape King Bio's annualized ROA % for the quarter that ended in Mar. 2025 is

ROA %=Net Income (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=830.588/( (15323.638+14939.803)/ 2 )
=830.588/15131.7205
=5.49 %

Note: The Net Income data used here is four times the quarterly (Mar. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Grape King Bio's Asset Turnover for the quarter that ended in Mar. 2025 is

Asset Turnover
=Revenue (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=2252.295/( (15323.638+14939.803)/ 2 )
=2252.295/15131.7205
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Grape King Bio Total Assets Related Terms

Thank you for viewing the detailed overview of Grape King Bio's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Grape King Bio Business Description

Traded in Other Exchanges
N/A
Address
No. 402, Jinling Road, Section 2, Pingzhen District, Taoyuan, TWN, 324
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicine, liquid tonic, drink, and healthy food. The company has three segments: MLM (Multi-Level Marketing) is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.

Grape King Bio Headlines

No Headlines